Study prompts new ideas on cancers' origins

December 16, 2017, Washington University School of Medicine
Graduate student Megan Radyk and Jason Mills, M.D., Ph.D., led a study revealing that although many cancer therapies target rapidly dividing stem cells, mature cells also seem to play a key role in initiating cancer, at least in forming precancerous lesions. Credit: Matt Miller

Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the origin of the disease.

Researchers at Washington University School of Medicine in St. Louis have found that mature cells have the ability to revert back to behaving more like rapidly dividing stem cells. However, when old cells return to a stem cell-like status, they can carry with them all of the mutations that have accumulated to date, predisposing some of those cells to developing into precancerous lesions.

The new study is published online in the journal Gastroenterology.

"As scientists, we have focused a good deal of attention on understanding the role of stem cells in the development of cancers, but there hasn't been a focus on mature cells," said senior investigator Jason C. Mills, MD, PhD, a professor of medicine in the Division of Gastroenterology. "But it appears when mature cells return back into a rapidly dividing stem cell state, this creates problems that can lead to cancer."

The findings, in mice and in human stomach cells, also raise questions about how may evade treatment.

Most cancer therapies are aimed at halting cancer growth by stopping cells from rapidly dividing. Such treatments typically attack stem cells but would not necessarily prevent mature cells from reverting to stem cell-like status.

Cancer therapies often target cells that grow and divide rapidly, such as stem cells, but in studying how stomach cancers occur, researchers at Washington University School of Medicine in St. Louis found that even when the stomach can't make stem cells, other cells in the stomach can begin to divide and contribute to precancerous lesions. Credit: Washington University BioMed Radio

"Cancer therapies target stem cells because they divide a lot, but if mature cells are being recruited to treat injuries, then those therapies won't touch the real problem," said first author Megan Radyk, a graduate student in Mills' laboratory. "If cancer recurs, it may be because the therapy didn't hit key mature cells that take on stem cell-like behavior. That can lead to the development of and, potentially, cancer."

Studying mice with injuries to the lining of the stomach, the researchers blocked the animals' ability to call on stem cells for help in the stomach. They focused on the stomach both because Mills is co-director of Washington University's NIH-supported Digestive Disease Center and because the anatomy in the stomach makes it easier to distinguish stem cells from mature cells that perform specific tasks. Even without stem cells, the mice developed a precancerous condition because mature stomach cells reverted back to a stem cell state to heal the injury.

Analyzing tissue specimens from 10 people with stomach cancer, the researchers found evidence that those same mature cells in the stomach also had reverted to a stem cell-like state and had begun to change and divide rapidly.

The Mills lab is working now to identify drugs that may block the by preventing mature cells from proliferating and dividing.

"Knowing these cells are leading to increased cancer risk may allow us to find drugs to keep mature from starting to divide and multiply," Mills said. "That may be important in preventing not only in the and GI tract but throughout the body."

Explore further: Researchers find stomach cancer pathway doesn't work as previously thought

More information: Megan D. Radyk et al, Metaplastic Cells in the Stomach Arise, Independently of Stem Cells, via Dedifferentiation or Transdifferentiation of Chief Cells, Gastroenterology (2017). DOI: 10.1053/j.gastro.2017.11.278

Related Stories

Researchers find stomach cancer pathway doesn't work as previously thought

January 23, 2017
Conventional wisdom holds that the loss of cells that secrete acid in the stomach leads to a condition that eventually can develop into stomach cancer.

Team discovers stem cells in the esophagus

October 16, 2014
Despite previous indications to the contrary, the esophagus does have its own pool of stem cells, said researchers from the University of Pittsburgh School of Medicine in an animal study published online today in Cell Reports. ...

Source of liver stem cells identified

August 5, 2015
Howard Hughes Medical Institute (HHMI) scientists have identified stem cells in the liver that give rise to functional liver cells. The work solves a long-standing mystery about the origin of new cells in the liver, which ...

Recommended for you

New breath and urine tests detect early breast cancer more accurately

April 25, 2018
A new method for early and accurate breast cancer screening has been developed by researchers at Ben-Gurion University of the Negev and Soroka University Medical Center, using commercially available technology.

Do prostate cancer cells have an Achilles' heel?

April 25, 2018
Researchers at the University of Illinois at Chicago describe new ways to selectively kill prostate cancer cells by exploiting the cells' revved-up metabolism. They report their findings in the online journal, eLife.

Research shows possible new target for immunotherapy for solid tumors

April 24, 2018
Research from the University of Cincinnati (UC) reveals a potential new target to help T cells (white blood cells) infiltrate certain solid tumors.

Changes in breast tissue increase cancer risk for older women

April 24, 2018
Researchers in Norway, Switzerland, and the United States have identified age-related differences in breast tissue that contribute to older women's increased risk of developing breast cancer. The findings, published April ...

Targeting molecules called miR-200s and ADAR2 could prevent tumor metastasis in patients with colorectal cancer

April 24, 2018
Colorectal cancer is the third most common cancer worldwide and the third-leading cause of cancer-related deaths. The main cause of death in patients with colorectal cancer is liver metastasis, with nearly 70% of patients ...

Experimental arthritis drug prevents stem cell transplant complication

April 24, 2018
An investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of stem cell transplants, new research from Washington University School of Medicine in St. Louis shows. ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

mdarr
5 / 5 (3) Dec 16, 2017
But presumably the mature to stem transition is important for the healing process. So just blocking the transition will create other problems.
Also the mature to stem transition is being explored for all sorts of therapies in the heart and other organs that don't normally heal. What does this research say about the future of those therapies.
Sounds like we need to know a lot more about the healthy vs problematic stem cell issue.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.